Analysts at StockNews.com assumed coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Get Free Report) in a research note issued to investors on Thursday. The firm set a “sell” rating on the biopharmaceutical company’s stock.
Onconova Therapeutics Price Performance
Onconova Therapeutics has a 1-year low of $0.55 and a 1-year high of $1.45. The company has a market cap of $20.90 million, a price-to-earnings ratio of -1.09 and a beta of 1.38. The firm’s 50 day moving average price is $0.85 and its two-hundred day moving average price is $0.74.
About Onconova Therapeutics
Featured Articles
- Five stocks we like better than Onconova Therapeutics
- Using the MarketBeat Dividend Tax Calculator
- AMD is Down 35%. Now is the Time to Buy the Dip
- Technology Stocks Explained: Here’s What to Know About Tech
- Amazon Stands Tall: New Highs Are in Sight
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Chesapeake Energy Stock is The Energy Play, Earnings Confirm
Receive News & Ratings for Onconova Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Onconova Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.